“Neutrophil activation marker CD15+ as a prognostic factor of ocular surface damage in type 2 diabetics”, Ukr. j. ophthalmol. , no. 1, pp. 15–19, Feb. 2024, doi: 10.31288/oftalmolzh202411519.